The future of memory.

The quest to build better people.
March 11 2003 3:32 PM

Total Recall

The future of memory.

(Continued from Page 1)
Remembering with the help of pharmaceuticals
Remembering with the help of pharmaceuticals

The Project The memory-drug companies don't like to speculate about memory enhancement. The FDA only approves drugs to treat the sick, not to improve the well. The companies could make enough repairing Alzheimer's victims that they don't need to push a just-for-the-fun-of-it memory boost.


That said, Cortex's Rogers and Memory's Unterbeck and Kandel believe that some of these compounds will be able to do just this. "It's not a goal for us with our current pipeline of drugs targeting Alzheimer's and depression," Unterbeck says. "But at some time, it might be possible to enhance normal memory performance."

Unterbeck and his colleagues have tested some of their compounds on normal healthy mice, and, he says, "We have shown we can improve their memory function quite a bit … with no side effects." But it remains to be shown, he adds, how such compounds perform in human clinical trials that are currently ongoing in healthy volunteers.

Cortex has tested Ampalex in healthy adults, and the results are promising. For a 1997 study, it gave a single dose of the drug to a group of Swedish medical students. After taking the drug, the students improved their performance on tests requiring them to identify smells, navigate mazes, and make visual associations.

If drugs such as Ampalex or Memory Pharmaceutical's molecules are found safe for impaired brains and approved by the FDA, doctors may start ordering them for younger people who are depressed, as a supplement to the usual anti-depressants. The military may prescribe them to soldiers to help them perform better in combat stress. And if the drugs prove harmless enough, doctors may eventually hand them out to high-schoolers before their SATs, or to actors before performances, or to you.

The Obstacles
The first memory drugs are in early clinical trials. No one knows if they are safe or what damage they might cause the brain over the long term. Data on how much they could boost memory function in healthy brains is sparse: The performance of mice and a few Swedish med students proves very little. Perhaps the drugs will not improve functioning memories, or perhaps they will work too well. Maybe patients will absorb too much information, cluttering their minds with useless details—the color of the shirt worn by a subway seatmate last Tuesday—and making it hard to focus on useful memories. We may need to forget just as much as we need to remember. (Other companies, in fact, are investigating forgetfulness drugs—compounds designed to help you lose a traumatic memory.)

The Timeline
If the clinical trials are a success, drugs from companies like Memory, Helicon, and Cortex might enter the Alzheimer's market in five to 10 years. But it would probably take at least a decade for any drug to filter into the mass market—just in time for Gen Y to get dosed for its MCATs and LSATs.


The World

The Budget Disaster that Sabotaged the WHO’s Response to Ebola

Are the Attacks in Canada a Sign of ISIS on the Rise in the West?

PowerPoint Is the Worst, and Now It’s the Latest Way to Hack Into Your Computer

Is It Offensive When Kids Use Bad Words for Good Causes?

Fascinating Maps Based on Reddit, Craigslist, and OkCupid Data


The Real Secret of Serial

What reporter Sarah Koenig actually believes.


The Actual World

“Mount Thoreau” and the naming of things in the wilderness.

In Praise of 13th Grade: Why a Fifth Year of High School Is a Great Idea

Can Democratic Sen. Mary Landrieu Pull Off One More Louisiana Miracle?

  News & Politics
The World
Oct. 23 2014 1:51 PM Is This the ISIS Backlash We've Been Waiting For?
Business Insider
Oct. 23 2014 2:36 PM Take a Rare Peek Inside the Massive Data Centers That Power Google
Atlas Obscura
Oct. 23 2014 1:34 PM Leave Me Be Beneath a Tree: Trunyan Cemetery in Bali
  Double X
The XX Factor
Oct. 23 2014 11:33 AM Watch Little Princesses Curse for the Feminist Cause
  Slate Plus
Oct. 23 2014 11:28 AM Slate’s Working Podcast: Episode 2 Transcript Read what David Plotz asked Dr. Meri Kolbrener about her workday.
Brow Beat
Oct. 23 2014 3:23 PM This Is What Bette Midler Covering TLC’s “Waterfalls” Sounds Like
Oct. 23 2014 11:45 AM The United States of Reddit  How social media is redrawing our borders. 
  Health & Science
Bad Astronomy
Oct. 23 2014 7:30 AM Our Solar System and Galaxy … Seen by an Astronaut
Sports Nut
Oct. 20 2014 5:09 PM Keepaway, on Three. Ready—Break! On his record-breaking touchdown pass, Peyton Manning couldn’t even leave the celebration to chance.